Literature DB >> 11742221

Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease.

J T Stieler1, C Lederer, M K Brückner, H Wolf, M Holzer, H J Gertz, T Arendt.   

Abstract

Cell-cycle dysregulation might be critically involved in the process of neurodegeneration in Alzheimer's disease (AD). We now provide evidence for a dysfunction of the cell division cycle as a more general cellular phenomenon of the disease. Peripheral blood lymphocytes, stimulated with mitogenic compounds, were less able to express CD69, an early proliferation marker, in AD patients than in age-matched controls. Expression levels of CD69 of both T-cells and B-cells correlated inversely with the Mini-mental Scale. The results suggest that a systemic failure of cellular proliferation control might be of critical importance for the pathomechanism of AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742221     DOI: 10.1097/00001756-200112210-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  Defects of immune regulation in the presenilin-1 mutant knockin mouse.

Authors:  Grant A Morgan; Qing Guo; Sic L Chan; Devin S Gary; Barbara A Osborne; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy.

Authors:  Katharina Schindowski; Anne Eckert; Jürgen Peters; Corinna Gorriz; Uta Schramm; Thomas Weinandi; Konrad Maurer; Lutz Frölich; Walter E Müller
Journal:  Neuromolecular Med       Date:  2007-10-26       Impact factor: 3.843

Review 3.  The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  Horm Behav       Date:  2015-07-16       Impact factor: 3.587

Review 4.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

5.  Altered cell viability and proliferation activity of peripheral lymphocytes in patients with Alzheimer's disease.

Authors:  Se Chang Yoon; Young-Ah Kwon; Hyeran Kim; Seonwoo Kim; Sangmee Ahn Jo; Doh Kwan Kim
Journal:  Psychiatry Investig       Date:  2010-03-03       Impact factor: 2.505

Review 6.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

7.  Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly.

Authors:  Agnieszka Jóźwik; Jerzy Landowski; Leszek Bidzan; Tamas Fülop; Ewa Bryl; Jacek M Witkowski
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

8.  Delirium from the gliocentric perspective.

Authors:  Adonis Sfera; Carolina Osorio; Amy I Price; Roberto Gradini; Michael Cummings
Journal:  Front Cell Neurosci       Date:  2015-05-11       Impact factor: 5.505

9.  Lymphocytes of patients with Alzheimer's disease display different DNA damage repair kinetics and expression profiles of DNA repair and stress response genes.

Authors:  Giovana S Leandro; Romulo R Lobo; Douglas V N P Oliveira; Julio C Moriguti; Elza T Sakamoto-Hojo
Journal:  Int J Mol Sci       Date:  2013-06-10       Impact factor: 5.923

Review 10.  PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease.

Authors:  Milena Morel; Julien Couturier; Claire Lafay-Chebassier; Marc Paccalin; Guylène Page
Journal:  J Cell Mol Med       Date:  2009-07-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.